Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Richmond, Virginia 23298


Purpose:

Within this study patient data are collected from different imaging and motion monitoring devices that will be used to develop and test strategies for image-guided adaptive radiotherapy in cervix cancer patients.


Criteria:

Inclusion Criteria: - Histological diagnosis of cervix cancer - Prescription of radiation treatment to the primary cancer Exclusion Criteria: - Prior radiation treatment to the pelvis


Study is Available At:


Original ID:

HM10390


NCT ID:

NCT00571415


Secondary ID:

P01CA116602


Study Acronym:


Brief Title:

Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition


Official Title:

Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition


Overall Status:

Suspended


Study Phase:

N/A


Genders:

Female


Minimum Age:

18 Years


Maximum Age:

N/A


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

Virginia Commonwealth University


Oversight Authority:

United States: Institutional Review Board


Reasons Why Stopped:

Due to competing studies no further subjects


Study Type:

Observational


Study Design:

Observational Model: Cohort, Time Perspective: Pro


Number of Arms:

0


Number of Groups:

1


Total Enrollment:

25


Enrollment Type:

Anticipated


Overall Contact Information

Official Name:Jeffrey F Williamson, PhD
Principal Investigator
Virginia Commonwealth University, Department of Radiation Oncology

Study Dates

Start Date:March 2009
Completion Date:December 2013
Completion Type:Anticipated
Primary Completion Date:December 2013
Primary Completion Type:Anticipated
Verification Date:December 2013
Last Changed Date:December 19, 2013
First Received Date:December 11, 2007

Study Outcomes

Outcome Type:Primary Outcome
Measure:Increase in therapeutic ratio
Time Frame:5 years
Safety Issues:False

Study Interventions

There are no available Study Interventions

Study Arms

Study Arm Type:Other
Arm Name:cervix cancer patients

Study Agencies

Agency Class:Other
Agency Type:Lead Sponsor
Agency Name:Virginia Commonwealth University
Agency Class:NIH
Agency Type:Collaborator
Agency Name:National Cancer Institute (NCI)

Samples and Retentions

Study Population: University hospital clinic
Sample Method:Probability Sample

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


This study is not currently recruiting Study Participants. The form below is not enabled.